Optimal management of endometrial hyperplasia.
The optimal management of endometrial hyperplasia is the subject of considerable debate. In this chapter the development of our current classification of endometrial hyperplasias is outlined in some detail in order to give an understanding of the complexity of the problem of determining the malignant potential of the hyperplasia which is the central issue in determining optimal treatment. While hysterectomy is still the definitive treatment for older women with hyperplasia, conservative therapy is perfectly acceptable in a defined group of younger women who are closely monitored.
Marsden
D E
DE
Gynaecological Cancer Centre, Royal Hospital for Women, Barker Street, Randwick, NSW, 2031 Australia.
Hacker
N F
NF
D003277:Contraceptives, Oral, Combined / Q000627:therapeutic use; D004107:Dilatation and Curettage / Q000379:methods; D004714:Endometrial Hyperplasia / Q000175:diagnosis / Q000628:therapy*; D005260:Female; D007987:Gonadotropin-Releasing Hormone / Q000031:analogs & derivatives / Q000627:therapeutic use; D006801:Humans; D007044:Hysterectomy / Q000379:methods; D008279:Magnetic Resonance Imaging / Q000379:methods; D045167:Progesterone Congeners / Q000627:therapeutic use
D003277:Contraceptives, Oral, Combined; D045167:Progesterone Congeners; D007987:Gonadotropin-Releasing Hormone